Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glioblastoma cells treated with MI3 or DMSO

ABSTRACT: Glioblastoma cells treated with MI3 or DMSO

PROVIDER: PRJNA627969 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11607607_1.fastq.gz	Fastqsanger.gz
	SRR11607607_2.fastq.gz	Fastqsanger.gz
	SRR11607608_1.fastq.gz	Fastqsanger.gz
	SRR11607608_2.fastq.gz	Fastqsanger.gz
	SRR11607609_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Gene expression of patient derived xenograft glioblastoma treated with DMSO control or Panobinostat.

Project description:Panobinostat is a non-selective histone deactylase inhibitor which has been approved by FDA for treatment of mutiple myeloma. Whether and how the drug works on glioblastoma remains unclear. Here we treated mice implanted with patient derived xenograft glioblastoma G43 with DMSO or Panobinostat and harvest the tumors for microarray analysis for gene expression results.

2019-01-09 | GSE108957 | GEO

RNAseq Analysis in glioblastoma cells treated with Mepazine

Project description:Glioblastoma cells were treated with vehicle (DMSO) or mepazine (MPZ, 20 μM, 4 hours) and prepared for RNAseq according to ActiveMotif standard procedure. The list of differentially expressed genes from DESeq2 output was selected based on 10% adjusted p-value level and FDR of 0.1.

2019-10-18 | GSE139018 | GEO

Gene expression of patient derived xenograft glioblastoma treated with DMSO control or Panobinostat.

Project description:Gene expression of patient derived xenograft glioblastoma treated with DMSO control or Panobinostat.

| PRJNA429241 | ENA

Human HepG2 cells: control DMSO vs. K7174-treated

Project description:Transcriptional profiling of human HepG2 cells comparing control DMSO-treated cells with K7174-treated cell

2014-08-01 | GSE48618 | GEO

Glioblastoma cells treated with MI3 or DMSO

Project description:Self-renewal is a crucial property of glioblastoma cells and is enabled by the choreographed function of chromatin regulators and transcription factors. Identifying targetable epigenetic mechanisms of self-renewal could represent an important step toward developing new and effective treatments for this universally lethal cancer. Here we uncover a targetable epigenetic axis of self-renewal mediated by the histone variant macroH2A2.

2023-02-15 | GSE149334 | GEO

Supplementary Dataset 27 - CHOPPER with DMSO-treated Jurkat cells

Project description:CHOPPER (Chemical enrichment of protease site with purchasable, elutable reagents, an N terminomics method) with DMSO-treated Jurkat cells

2023-02-11 | MSV000091273 | MassIVE

Supplementary Dataset 29 - HUNTER with DMSO-treated Jurkat cells

Project description:HUNTER analysis of N-terminal peptides from Jurkat cells treated with DMSO for 8 h. Control for Supplementary Dataset 28.

2023-06-21 | MSV000092233 | MassIVE

Exosomal miRNA profile of BNCT treated glioblastoma cells

Project description:Exosomal miRNA profile of BNCT treated glioblastoma cells

| PRJNA1017425 | ENA

RNAseq Analysis in glioblastoma cells treated with Mepazine

Project description:RNAseq Analysis in glioblastoma cells treated with Mepazine

| PRJNA578094 | ENA

RNA-seq of K562 cells treated with the FTO inhibitor CS2 compared to DMSO treated cells

Project description:RNA-seq of K562 cells treated with the FTO inhibitor CS2 compared to DMSO treated cells